Clinical Outcomes After Caval Valve Implantation for Severe Symptomatic Tricuspid Regurgitation: A Meta-Analysis.

[1]  M. De Carlo,et al.  Heterotopic Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation and Refractory Right Heart Failure , 2022, JACC. Case reports.

[2]  A. Iñíguez-Romo,et al.  Six-Month Outcomes of the TricValve® System in Patients with Tricuspid Regurgitation: TRICUS EURO Study. , 2022, JACC. Cardiovascular interventions.

[3]  A. Unbehaun,et al.  Early Clinical Experience With the TRICENTO Bicaval Valved Stent for Treatment of Symptomatic Severe Tricuspid Regurgitation: A Multicenter Registry , 2022, Circulation. Cardiovascular interventions.

[4]  Y. Mehta,et al.  Heterotopic caval valve implantation in severe tricuspid regurgitation , 2021, Annals of cardiac anaesthesia.

[5]  R. Laham,et al.  Heterotopic caval valve implantation for the management of severe tricuspid regurgitation: a case series , 2020, European heart journal. Case reports.

[6]  Ignacio J. Amat-Santos,et al.  Tratamiento percutáneo de la insuficiencia tricuspídea grave con dispositivo TRICENTO. Experiencia inicial y seguimiento a medio plazo , 2020 .

[7]  A. Bavry,et al.  Percutaneous Inferior Vena Cava Valve Implantation May Improve Tricuspid Valve Regurgitation and Cardiac Output: Lessons Learned , 2020, Innovations.

[8]  W. O’Neill,et al.  Caval Valve Implantation for Tricuspid Regurgitation: Insights From the United States Caval Valve Registry. , 2020, The Journal of invasive cardiology.

[9]  M. Laule,et al.  Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  G. Laufer,et al.  Transcatheter Caval Valve Implantation of the Tricento Valve for Tricuspid Regurgitation Using Advanced Intraprocedural Imaging , 2019, JACC. Case reports.

[11]  R. Kobza,et al.  First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  J. Hausleiter,et al.  Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study , 2018, Circulation. Cardiovascular interventions.

[13]  V. Rakita,et al.  Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  M. Laule,et al.  Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. , 2013, Journal of the American College of Cardiology.

[15]  Alexander Lauten,et al.  Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation , 2011, European heart journal.